The relationship between C-reactive protein and atherosclerosis differs on the basis of body mass index: The dallas heart study

Journal of the American College of Cardiology

Volumn 60, Issue 13, 2012, Pages 1148-1155

  Gupta, Nitin K ^a   De Lemos, James A ^a,b   Ayers, Colby R ^b   Abdullah, Shuaib M ^a,b   McGuire, Darren K ^a,b   Khera, Amit ^a,b  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^b UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

atherosclerosis; inflammation; obesity

Indexed keywords

C REACTIVE PROTEIN;

ACCURACY; ADULT; ARTERIAL WALL THICKNESS; ARTICLE; ATHEROSCLEROSIS; BODY MASS; CARDIOVASCULAR DISEASE; CORONARY ARTERY CALCIFICATION; FEMALE; HUMAN; MALE; MORBID OBESITY; NUCLEAR MAGNETIC RESONANCE IMAGING; OBESITY; PHENOTYPE; PREVALENCE; PRIORITY JOURNAL; RISK FACTOR;

ADULT; AORTA; BODY MASS INDEX; C-REACTIVE PROTEIN; COHORT STUDIES; CORONARY ARTERY DISEASE; CORONARY VESSELS; FEMALE; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; OBESITY; PLAQUE, ATHEROSCLEROTIC; PREVALENCE; TOMOGRAPHY, X-RAY COMPUTED; VASCULAR CALCIFICATION;

EID: 84866366621     PISSN: 07351097     EISSN: 15583597     Source Type: Journal    
DOI: 10.1016/j.jacc.2012.04.050     Document Type: Article

References (39)

1. C.M. Albert, J. Ma, N. Rifai, M.J. Stampfer, P.M. Ridker Prospective study of C-reactive protein, homocysteine, and plasma lipid levels as predictors of sudden cardiac death Circulation 105 2002 2595 2599
2. J. Danesh, J.G. Wheeler, G.M. Hirschfield C-reactive protein and other circulating markers of inflammation in the prediction of coronary heart disease N Engl J Med 350 2004 1387 1397
3. W. Koenig, M. Sund, M. Frohlich C-Reactive protein, a sensitive marker of inflammation, predicts future risk of coronary heart disease in initially healthy middle-aged men: results from the MONICA (Monitoring Trends and Determinants in Cardiovascular Disease) Augsburg Cohort Study, 1984 to 1992 Circulation 99 1999 237 242
4. L.H. Kuller, R.P. Tracy, J. Shaten, E.N. Meilahn Relation of C-reactive protein and coronary heart disease in the MRFIT nested case-control study Multiple Risk Factor Intervention Trial Am J Epidemiol 144 1996 537 547
5. A. Festa, R. D'Agostino Jr., K. Williams The relation of body fat mass and distribution to markers of chronic inflammation Int J Obes Relat Metab Disord 25 2001 1407 1415
6. A.D. Pradhan, J.E. Manson, J.E. Rossouw Inflammatory biomarkers, hormone replacement therapy, and incident coronary heart disease: prospective analysis from the Women's Health Initiative observational study JAMA 288 2002 980 987
7. P.M. Ridker, J.E. Buring, J. Shih, M. Matias, C.H. Hennekens Prospective study of C-reactive protein and the risk of future cardiovascular events among apparently healthy women Circulation 98 1998 731 733
8. P.M. Ridker, M. Cushman, M.J. Stampfer, R.P. Tracy, C.H. Hennekens Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men N Engl J Med 336 1997 973 979
9. N.S. Rost, P.A. Wolf, C.S. Kase Plasma concentration of C-reactive protein and risk of ischemic stroke and transient ischemic attack: the Framingham study Stroke 32 2001 2575 2579
10. S. Mora, N. Rifai, J.E. Buring, P.M. Ridker Additive value of immunoassay-measured fibrinogen and high-sensitivity C-reactive protein levels for predicting incident cardiovascular events Circulation 114 2006 381 387
11. P.M. Ridker, N. Rifai, L. Rose, J.E. Buring, N.R. Cook Comparison of C-reactive protein and low-density lipoprotein cholesterol levels in the prediction of first cardiovascular events N Engl J Med 347 2002 1557 1565
12. K.M. Flegal, M.D. Carroll, C.L. Ogden, L.R. Curtin Prevalence and trends in obesity among US adults, 1999-2008 JAMA 303 2010 235 241
13. A. Khera C-reactive protein J.A. De Lemos, Biomarkers in Heart Disease 2008 Blackwell Publishing Malden 161 180
14. P. Libby Inflammation in atherosclerosis Nature 420 2002 868 874
15. M.B. Pepys, G.M. Hirschfield C-reactive protein: a critical update J Clin Invest 111 2003 1805 1812
16. V. Mohamed-Ali, S. Goodrick, A. Rawesh Subcutaneous adipose tissue releases interleukin-6, but not tumor necrosis factor-alpha, in vivo J Clin Endocrinol Metab 82 1997 4196 4200
17. J.S. Yudkin, M. Kumari, S.E. Humphries, V. Mohamed-Ali Inflammation, obesity, stress and coronary heart disease: is interleukin-6 the link? Atherosclerosis 148 2000 209 214
18. R.G. Victor, R.W. Haley, D.L. Willett The Dallas Heart Study: a population-based probability sample for the multidisciplinary study of ethnic differences in cardiovascular health Am J Cardiol 93 2004 1473 1480
19. A. Khera, D.K. McGuire, S.A. Murphy Race and gender differences in C-reactive protein levels J Am Coll Cardiol 46 2005 464 469
20. A.S. Agatston, W.R. Janowitz, F.J. Hildner, N.R. Zusmer, M. Viamonte Jr., R. Detrano Quantification of coronary artery calcium using ultrafast computed tomography J Am Coll Cardiol 15 1990 827 832
21. T. Jain, R. Peshock, D.K. McGuire African Americans and Caucasians have a similar prevalence of coronary calcium in the Dallas Heart Study J Am Coll Cardiol 44 2004 1011 1017
22. E.B. Rosero, R.M. Peshock, A. Khera, G.P. Clagett, H. Lo, C. Timaran Agreement between methods of measurement of mean aortic wall thickness by MRI J Magn Reson Imaging 29 2009 576 582
23. F.A. Jaffer, C.J. O'Donnell, M.G. Larson Age and sex distribution of subclinical aortic atherosclerosis: a magnetic resonance imaging examination of the Framingham Heart Study Arterioscler Thromb Vasc Biol 22 2002 849 854
24. A. Rohatgi, A.W. Owens, A. Khera Differential associations between soluble cellular adhesion molecules and atherosclerosis in the Dallas Heart Study: a distinct role for soluble endothelial cell-selective adhesion molecule Arterioscler Thromb Vasc Biol 29 2009 1684 1690
25. Executive summary of the clinical guidelines on the identification, evaluation, and treatment of overweight and obesity in adults Arch Intern Med 158 1998 1855 1867
26. Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III) JAMA 285 2001 2486 2497
27. T.A. Pearson, G.A. Mensah, R.W. Alexander Markers of inflammation and cardiovascular disease: application to clinical and public health practice: a statement for healthcare professionals from the Centers for Disease Control and Prevention and the American Heart Association Circulation 107 2003 499 511
28. A. Khera, G.L. Vega, S.R. Das Sex differences in the relationship between C-reactive protein and body fat J Clin Endocrinol Metab 94 2009 3251 3258
29. H.L. Walls, C.E. Stevenson, H.R. Mannan Comparing trends in BMI and waist circumference Obesity (Silver Spring) 19 2011 216 219
30. L.G. Best, Y. Zhang, E.T. Lee C-reactive protein as a predictor of cardiovascular risk in a population with a high prevalence of diabetes: the Strong Heart Study Circulation 112 2005 1289 1295
31. S.G. Lakoski, A.H. Le, P. Muntner Adiposity, inflammation, and risk for death in black and white men and women in the united states: the Reasons for Geographic and Racial Differences in Stroke (REGARDS) Study J Clin Endocrinol Metab 96 2011 1805 1814
32. S. Kathiresan, M.G. Larson, R.S. Vasan Contribution of clinical correlates and 13 C-reactive protein gene polymorphisms to interindividual variability in serum C-reactive protein level Circulation 113 2006 1415 1423
33. P.M. Ridker, C.P. Cannon, D. Morrow C-reactive protein levels and outcomes after statin therapy N Engl J Med 352 2005 20 28
34. L.M. Biasucci, F. Graziani, V. Rizzello Paradoxical preservation of vascular function in severe obesity Am J Med 123 2010 727 734
35. F. Graziani, P. Cialdella, G. Liuzzo Cardiovascular risk in obesity: different activation of inflammation and immune system between obese and morbidly obese subjects Eur J Intern Med 22 2011 418 423
36. D. Gallagher, M. Visser, D. Sepulveda, R.N. Pierson, T. Harris, S.B. Heymsfield How useful is body mass index for comparison of body fatness across age, sex, and ethnic groups? Am J Epidemiol 143 1996 228 239
37. P.M. Ridker, J.E. Buring, N.R. Cook, N. Rifai C-reactive protein, the metabolic syndrome, and risk of incident cardiovascular events: an 8-year follow-up of 14 719 initially healthy American women Circulation 107 2003 391 397
38. A. Khera, J.A. de Lemos, R.M. Peshock Relationship between C-reactive protein and subclinical atherosclerosis: the Dallas Heart Study Circulation 113 2006 38 43
39. A.P. Burke, R.P. Tracy, F. Kolodgie Elevated C-reactive protein values and atherosclerosis in sudden coronary death: association with different pathologies Circulation 105 2002 2019 2023